40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Lower upside than VET's upside of 42.44%.
Buy
Equal to VET's analyst recommendation of Buy.
Analyze analyst forecasts for the company and compare them with competitors.
4.88B
Better than VET's estimated revenue of 1.57B.
1.41B
Better than VET's estimated ebitda of 775.05M.
3.32
Better than VET's estimated eps of -0.02.
1.02B
Better than VET's estimated net income of 764.21M.
1.57B
Better than VET's estimated ebit of 1.07B.
126.88M
Better than VET's estimated sg&a expense of 474.46M.
Analyze DCF forecasts for the company and compare them with competitors.
6.73B
Better than VET's revenue of 1.32B.
No Data
No DCF data available for this metric in the selected year.
2.75B
Better than VET's ebitda of 635.00M.
40.87%
Worse than VET's ebitda margin of 48.00%.
697.00M
Better than VET's ebit of 144.97M.
10.36%
Worse than VET's ebit margin of 10.96%.
2.05B
Worse than VET's depreciation of 490.03M.
190.00M
Better than VET's total cash of 20.10M.
2.82%
Better than VET's cash as percentage of revenue of 1.52%.
1.15B
Worse than VET's receivables of 146.35M.
17.04%
Worse than VET's receivables as percentage of revenue of 11.06%.
7.00M
Better than VET's inventories of 20.35M.
0.10%
Better than VET's inventories as percentage of revenue of 1.54%.
348.00M
Worse than VET's accounts payable of 171.27M.
5.17%
Better than VET's payables as percentage of revenue of 12.95%.
-2.63B
Better than VET's capital expenditure of -362.18M.
-39.04%
Better than VET's capex as percentage of revenue of -27.37%.
11.70%
Better than VET's weighted average cost of capital (wacc) of 11.98%.
16.87%
Worse than VET's cost of equity of 16.56%.
5.31%
Better than VET's cost of debt of 9.00%.
2.64
Worse than VET's beta of 2.58.
263.90M
Worse than VET's diluted shares outstanding of 163.72M.
6.68B
Worse than VET's total debt of 655.60M.
10.03B
Better than VET's total equity of 1.42B.
16.71B
Better than VET's total capital of 2.07B.
39.98%
Worse than VET's debt weighting of 31.64%.
60.02%
Worse than VET's equity weighting of 68.36%.
517.77M
Better than VET's ebiat of 33.69M.
-861.23M
Worse than VET's unlevered free cash flow of 166.11M.
0.50%
Worse than VET's long-term growth rate of 2.00%.
-12.22B
Worse than VET's terminal value of 5.64B.
-11.02B
Worse than VET's enterprise value of 4.72B.
6.68B
Worse than VET's net debt of 557.67M.
-17.70B
Worse than VET's equity value of 4.17B.
-67.06
Worse than VET's equity value per share of 25.44.
